Predictors and clinical complications associated with antiphospholipid antibodies in sickle cell disease
Abstract Although a higher prevalence of antiphospholipid autoantibodies (aPL) has been observed in some cohorts of sickle cell disease (SCD) patients, the clinical risk factors for the development of aPL and its associated complications remain unclear. In a retrospective study of 63 SCD patients, a...
Main Authors: | Claudia Rodriguez Rivera, Andrew Srisuwananukorn, Rizma Jalees Bajwa, Victor R. Gordeuk, Joyce Rauch, Jerrold S. Levine, Santosh L. Saraf |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | eJHaem |
Subjects: | |
Online Access: | https://doi.org/10.1002/jha2.643 |
Similar Items
-
ANTIPHOSPHOLIPID SYNDROME: DIAGNOSIS AND CLINICAL MANIFESTATIONS (A LECTURE)
by: Tat’yana M Reshetnyak
Published: (2014-03-01) -
Primary antiphospholipid syndrome progressing to systemic lupus erythematosus: a case report
by: Rocco Manganelli, et al.
Published: (2013-04-01) -
The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus
by: M. Taraborelli, et al.
Published: (2016-12-01) -
Pediatric antiphospholipid syndrome
by: Petrović Gordana, et al.
Published: (2023-01-01) -
Type I interferon pathway activation across the antiphospholipid syndrome spectrum: associations with disease subsets and systemic antiphospholipid syndrome presentation
by: Irene Cecchi, et al.
Published: (2024-03-01)